Breaking News, Collaborations & Alliances

Emmes Partners with MedGenome to Accelerate Breakthrough Treatments

Partnership focuses on advancing rare disease research.

Author Image

By: Charlie Sternberg

Associate Editor

Emmes, a global, full-service Clinical Research Organization (CRO), has announced a partnership with MedGenome aimed at accelerating breakthrough treatments, powered by human genomics, for rare disease patients.   “This is an exciting opportunity to partner with the leading genetic testing laboratory in India and South Asia to use our collective expertise to help bring faster and more innovative treatments to patients around the world who are suffering from rare diseases and desperately aw...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters